
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Lipid based formulations as supersaturating oral delivery systems: From current to future industrial applications
René Holm, Martin Kuentz, Alexandra-Roxana Ilie-Spiridon, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 189, pp. 106556-106556
Open Access | Times Cited: 21
René Holm, Martin Kuentz, Alexandra-Roxana Ilie-Spiridon, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 189, pp. 106556-106556
Open Access | Times Cited: 21
Showing 21 citing articles:
Self-Emulsifying Drug Delivery Systems (SEDDS): Transition from Liquid to Solid—A Comprehensive Review of Formulation, Characterization, Applications, and Future Trends
Prateek Uttreja, Indrajeet Karnik, Ahmed Adel Ali Youssef, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 63-63
Open Access | Times Cited: 1
Prateek Uttreja, Indrajeet Karnik, Ahmed Adel Ali Youssef, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 63-63
Open Access | Times Cited: 1
Pharmaceutical approaches for enhancing solubility and oral bioavailability of poorly soluble drugs
Isaïe Nyamba, Charles B Sombié, Moussa Yabré, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024), pp. 114513-114513
Closed Access | Times Cited: 11
Isaïe Nyamba, Charles B Sombié, Moussa Yabré, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024), pp. 114513-114513
Closed Access | Times Cited: 11
Repaglinide–Solid Lipid Nanoparticles in Chitosan Patches for Transdermal Application: Box–Behnken Design, Characterization, and In Vivo Evaluation
Hany S.M. Ali, Nader Ibrahim Namazi, Hossein M. Elbadawy, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 209-230
Open Access | Times Cited: 10
Hany S.M. Ali, Nader Ibrahim Namazi, Hossein M. Elbadawy, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 209-230
Open Access | Times Cited: 10
Abiraterone acetate fixed-dosed combinations with ibuprofen-based therapeutic eutectic and deep eutectic solvents
Shaida Panbachi, Josef Beránek, Martin Kuentz
International Journal of Pharmaceutics (2025), pp. 125279-125279
Open Access
Shaida Panbachi, Josef Beránek, Martin Kuentz
International Journal of Pharmaceutics (2025), pp. 125279-125279
Open Access
Dynamic changes in the distribution equilibrium of drugs in microemulsions associated with drug absorption facilitate the absorption improvement for drugs with low water-solubility by self-microemulsifying drug delivery system (SMEDDS)
S Nishiyama, Yuki Takemoto, Keita Yamanouchi, et al.
International Journal of Pharmaceutics (2025), pp. 125458-125458
Closed Access
S Nishiyama, Yuki Takemoto, Keita Yamanouchi, et al.
International Journal of Pharmaceutics (2025), pp. 125458-125458
Closed Access
Utilization of Lipophilic Salt and Phospholipid Complex in Lipid-Based Formulations to Modulate Drug Loading and Oral Bioavailability of Pazopanib
Karan Jadhav, Arvind Sirvi, Akash Janjal, et al.
AAPS PharmSciTech (2024) Vol. 25, Iss. 3
Closed Access | Times Cited: 4
Karan Jadhav, Arvind Sirvi, Akash Janjal, et al.
AAPS PharmSciTech (2024) Vol. 25, Iss. 3
Closed Access | Times Cited: 4
Enabling superior drug loading in lipid-based formulations with lipophilic salts for a brick dust molecule: Exploration of lipophilic counterions and in vitro-in vivo evaluation
Arvind Sirvi, Karan Jadhav, Abhay T. Sangamwar
International Journal of Pharmaceutics (2024) Vol. 656, pp. 124108-124108
Closed Access | Times Cited: 4
Arvind Sirvi, Karan Jadhav, Abhay T. Sangamwar
International Journal of Pharmaceutics (2024) Vol. 656, pp. 124108-124108
Closed Access | Times Cited: 4
Absorption of cinnarizine from type II lipid-based formulations: Impact of lipid chain length, supersaturation, digestion, and precipitation inhibition
Felix Paulus, René Holm, Jef Stappaerts, et al.
European Journal of Pharmaceutical Sciences (2024) Vol. 197, pp. 106765-106765
Open Access | Times Cited: 3
Felix Paulus, René Holm, Jef Stappaerts, et al.
European Journal of Pharmaceutical Sciences (2024) Vol. 197, pp. 106765-106765
Open Access | Times Cited: 3
Phospholipid Complex Formulation Technology for Improved Drug Delivery in Oncological Settings: a Comprehensive Review
Jayesh Patil, Datta Maroti Pawde, Sankha Bhattacharya, et al.
AAPS PharmSciTech (2024) Vol. 25, Iss. 5
Closed Access | Times Cited: 2
Jayesh Patil, Datta Maroti Pawde, Sankha Bhattacharya, et al.
AAPS PharmSciTech (2024) Vol. 25, Iss. 5
Closed Access | Times Cited: 2
Exploring the landscape of Lipid Nanoparticles (LNPs): A comprehensive review of LNPs types and biological sources of lipids
Alanood S Alfutaimani, N Alharbi, Amirah Alahmari, et al.
International Journal of Pharmaceutics X (2024) Vol. 8, pp. 100305-100305
Open Access | Times Cited: 2
Alanood S Alfutaimani, N Alharbi, Amirah Alahmari, et al.
International Journal of Pharmaceutics X (2024) Vol. 8, pp. 100305-100305
Open Access | Times Cited: 2
Rationalizing Counterion Selection for the Development of Lipophilic Salts: A Case Study with Venetoclax
Callum D. Ryan, Brendan T. Griffin, Joseph P. O’Shea
Molecular Pharmaceutics (2024) Vol. 21, Iss. 6, pp. 2981-2992
Open Access | Times Cited: 1
Callum D. Ryan, Brendan T. Griffin, Joseph P. O’Shea
Molecular Pharmaceutics (2024) Vol. 21, Iss. 6, pp. 2981-2992
Open Access | Times Cited: 1
Lipid-based systems with precipitation inhibitors as formulation approach to improve the drug bioavailability and/or lower its dose: a review
M Kovacevic, Mirjana Gašperlin, Alenka Zvonar Pobirk
Acta Pharmaceutica (2024) Vol. 74, Iss. 2, pp. 201-227
Open Access | Times Cited: 1
M Kovacevic, Mirjana Gašperlin, Alenka Zvonar Pobirk
Acta Pharmaceutica (2024) Vol. 74, Iss. 2, pp. 201-227
Open Access | Times Cited: 1
Thermally-Induced Supersaturation Approach for Optimizing Drug Loading and Biopharmaceutical Properties of Supersaturated Lipid-Based Formulations: Case Studies with Ibrutinib and Enzalutamide
Arvind Sirvi, Akash Janjal, Kajal Guleria, et al.
AAPS PharmSciTech (2024) Vol. 25, Iss. 7
Closed Access | Times Cited: 1
Arvind Sirvi, Akash Janjal, Kajal Guleria, et al.
AAPS PharmSciTech (2024) Vol. 25, Iss. 7
Closed Access | Times Cited: 1
Combination of co-amorphization with SNEDDS outperforms Ofev® in the oral absorption of nintedanib
Tomoya Inoue, S. Maehara, Masato Maruyama, et al.
International Journal of Pharmaceutics (2024) Vol. 657, pp. 124197-124197
Closed Access
Tomoya Inoue, S. Maehara, Masato Maruyama, et al.
International Journal of Pharmaceutics (2024) Vol. 657, pp. 124197-124197
Closed Access
Cinnamon oil-based self-emulsifying system for augmented dissolution and hypoglycemic efficacy of gliquidone
Mohamed El-Araby, Sanaa A. El‐Gizawy, Shimaa M. Ashmawy, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 97, pp. 105821-105821
Closed Access
Mohamed El-Araby, Sanaa A. El‐Gizawy, Shimaa M. Ashmawy, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 97, pp. 105821-105821
Closed Access
Contrasting the pharmacokinetic performance and gut microbiota effects of an amorphous solid dispersion and lipid nanoemulsion for a poorly water-soluble anti-psychotic
Tahlia R. Meola, Srinivas Kamath, Aurelia S. Elz, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 203, pp. 114453-114453
Open Access
Tahlia R. Meola, Srinivas Kamath, Aurelia S. Elz, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 203, pp. 114453-114453
Open Access
Exploration of solubilisation effects facilitated by the combination of Soluplus® with ionic surfactants
Justus Johann Lange, Lukas Enzner, Martin Kuentz, et al.
European Journal of Pharmaceutical Sciences (2024), pp. 106957-106957
Open Access
Justus Johann Lange, Lukas Enzner, Martin Kuentz, et al.
European Journal of Pharmaceutical Sciences (2024), pp. 106957-106957
Open Access
Influence of polymer and surfactant-based precipitation inhibitors on supersaturation-driven absorption of Ibrutinib from high-dose lipid-based formulations
Arvind Sirvi, Akash Janjal, Shubham Debaje, et al.
International Journal of Pharmaceutics (2024) Vol. 669, pp. 125079-125079
Closed Access
Arvind Sirvi, Akash Janjal, Shubham Debaje, et al.
International Journal of Pharmaceutics (2024) Vol. 669, pp. 125079-125079
Closed Access
Ketoconazole-Fumaric Acid Pharmaceutical Cocrystal: From Formulation Design for Bioavailability Improvement to Biocompatibility Testing and Antifungal Efficacy Evaluation
Ioana Bâldea, Remus Moldovan, András Nagy, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13346-13346
Open Access
Ioana Bâldea, Remus Moldovan, András Nagy, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13346-13346
Open Access
Influence de l’hydroxypropyl-β-Cyclodextrine et de l’hydroxypropyl-γ-Cyclodextrine sur la solubilité aqueuse de l’acide ellagique
Isaïe Nyamba, Bertrand Goumbri, B. Charles Sombié, et al.
Journal Africain de Technologie Pharmaceutique et Biopharmacie (JATPB) (2024) Vol. 3, Iss. 2, pp. 45-52
Open Access
Isaïe Nyamba, Bertrand Goumbri, B. Charles Sombié, et al.
Journal Africain de Technologie Pharmaceutique et Biopharmacie (JATPB) (2024) Vol. 3, Iss. 2, pp. 45-52
Open Access
New Series of 3-Pyridyl-1,3-Thiazoles: In Vitro and In Vivo Anti-Trypanosomatidae Profile, in vitro and in silico Mechanism of Action approach
Vanessa Gouveia de Melo Silva, Luciana Sousa, Expedito Lopes Fernandes, et al.
European Journal of Medicinal Chemistry (2024) Vol. 284, pp. 117191-117191
Closed Access
Vanessa Gouveia de Melo Silva, Luciana Sousa, Expedito Lopes Fernandes, et al.
European Journal of Medicinal Chemistry (2024) Vol. 284, pp. 117191-117191
Closed Access